Induction of lethal bystander effects in human breast cancer cell cultures by DNA-incorporated Iodine-125 depends on phenotype

International Journal of Radiation Biology

Volumn 88, Issue 12, 2012, Pages 1028-1038

  Akudugu, John M ^a,b   Azzam, Edouard I ^a   Howell, Roger W ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Auger electron; Breast cancer; Bystander effects; Human tumour cells; I 125; Iododeoxyuridine

Indexed keywords

IDOXURIDINE; IODINE 125;

ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; BYSTANDER EFFECT; CANCER CELL CULTURE; CELL LABELING; COLONY FORMATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOARCHITECTURE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

ANIMALS; BREAST NEOPLASMS; BYSTANDER EFFECT; CELL DEATH; CELL SURVIVAL; DEOXYURIDINE; DNA; HUMANS; IDOXURIDINE; IODINE RADIOISOTOPES; MCF-7 CELLS; MICE; PHENOTYPE;

MUS MUSCULUS;

EID: 84870565831     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2012.683511     Document Type: Conference Paper

References (51)

1. Akudugu JM, Neti PVSV, Howell RW. 2011. Changes in lognormal shape parameter guide design of patient-specific radiochemotherapy cocktails. Journal of Nuclear Medicine 52: 642-649.
2. Autsavapromporn N, De Toledo SM, Buonanno M, Jay-Gerin JP, Harris AL, Azzam EI. 2011. Intercellular communication amplifies stressful effects in high-charge, high-energy (HZE) particle-irradiated human cells. Journal of Radiation Research 52: 408-414.
3. Azzam EI, de Toledo SM, Gooding T, Little JB. 1998. Intercellular communication is involved in the bystander regulation of gene expression in human cells exposed to very low fluences of alpha particles. Radiation Research 150: 497-504.
4. Bishayee A, Rao DV, Howell RW. 1999. Evidence for pronounced bystander effects caused by nonuniform distributions of radioactivity using a novel three-dimensional tissue culture model. Radiation Research 152: 88-97.
5. Bishayee A, Hill HZ, Stein D, Rao DV, Howell RW. 2001. Free-radical initiated and gap junction-mediated bystander effect due to nonuniform distribution of incorporated radioactivity in a three-dimensional tissue culture model. Radiation Research 155: 335-344.
6. Blyth BJ, Azzam EI, Howell RW, Ormsby RJ, Staudacher AH, Sykes PJ. 2010. An adoptive transfer method to detect low-dose radiation-induced bystander effects in vivo. Radiation Research 173: 125-137.
7. Blyth BJ, Sykes PJ. 2011. Radiation-induced bystander effects: What are they, and how relevant are they to human radiation exposures? Radiation Research 176: 139-157.
8. Boyd M, Ross SC, Dorrens J, Fullerton NE, Tan KW, Zalutsky MR, Mairs RJ. 2006. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and Auger electron-emitting radionuclides. Journal of Nuclear Medicine 47: 1007-1015.
9. Boyd M, Sorensen A, McCluskey AG, Mairs RJ. 2008. Radiation quality- dependent bystander effects elicited by targeted radionuclides. Journal of Pharmacy and Pharmacology 60: 951-958.
10. Brooks AL, Retherford JC, McClellan RO. 1974. Effect of 239PuO2 particle number and size on the frequency and distribution of chromosome aberrations in the liver of the Chinese hamster. Radiation Research 59: 693-709.
11. Buonanno M, de Toledo SM, Azzam EI. 2011. Increased frequency of spontaneous neoplastic transformation in progeny of bystander cells from cultures exposed to densely ionizing radiation. PloS One 6: e21540.
12. Feinendegen LE. 1967. Tritium-labeled molecules in biology and medicine. New York: Academic Press. 430 p.
13. Foulon CF, Zhang YZ, Adelstein SJ, Kassis AI. 1995. Instantaneous preparation of radiolabeled 5-iodo-2-deoxyuridine. Applied Radiation and Isotopes 46: 1039-1046.
14. Gerashchenko BI, Howell RW. 2004. Proliferative response of bystander cells adjacent to cells with incorporated radioactivity. Cytometry 60A: 155-164.
15. Gerashchenko BI, Howell RW. 2005. Bystander cell proliferation is modulated by the number of adjacent cells that were exposed to ionizing radiation. Cytometry A 66A: 62-70.
16. Goddu SM, Howell RW, Bouchet LG, Bolch WE, Rao DV. 1997. MIRD Cellular S values: Self-absorbed dose per unit cumulated activity for selected radionuclides and monoenergetic electron and alpha particle emitters incorporated into different cell compartments. Reston, VA: Society of Nuclear Medicine. 183 p.
17. Hahnel A, Wichmann H, Kappler M, Kotzsch M, Vordermark D, Taubert H, Bache M. 2010. Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells. Radiation Oncology 5: 82.
18. Horikawa M, Doida Y, Sugahara T. 1963. Preliminary studies on cytosis in mammalian cells cultured in vitro. Experimental cell research 32: 404-407.
19. Howell RW, Rao DV, Sastry KSR. 1989. Macroscopic dosimetry for radioimmunotherapy: Nonuniform activity distributions in solid tumors. Medical Physics 16: 66-74.
20. Howell RW, Rao DV, Hou D-Y, Narra VR, Sastry KSR. 1991. The question of relative biological effectiveness and quality factor for Auger emitters incorporated into proliferating mammalian cells. Radiation Research 128: 282-292.
21. Howell RW, Bishayee A. 2002. Bystander effects caused by nonuniform distributions of DNA-incorporated 125I. Micron 33: 127-132.
22. Howell RW, Neti PV, Pinto M, Gerashchenko BI, Narra VR, Azzam EI. 2006. Challenges and progress in predicting biological responses to incorporated radioactivity. Radiation Protection Dosimetry 122: 521-527.
23. Humm JL. 1986. Dosimetric aspects of radiolabeled antibodies for tumor therapy. Journal of Nuclear Medicine 27: 1490-1497.
24. Jain S, Coulter JA, Hounsell AR, Butterworth KT, McMahon SJ, Hyland WB, Muir MF, Dickson GR, Prise KM, Currell FJ, et al. 2011. Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. International Journal of Radiation Oncology, Biology, and Physics 79: 531-539.
25. Jönsson B-A, Strand S-E, Larsson BS. 1992. A quantitative autoradiographic study of the heterogeneous activity distribution of different indium-111-labeled radiopharmaceuticals in rat tissues. Journal of Nuclear Medicine 33: 1825-1832.
26. Kassis AI, Fayad F, Kinsey BM, Sastry KSR, Taube RA, Adelstein SJ. 1987a. Radiotoxicity of I-125 in mammalian cells. Radiation Research 111: 305-318.
27. Kassis AI, Sastry KSR, Adelstein SJ. 1987b. Kinetics of uptake, retention, and radiotoxicity of 125IUdR in mammalian cells: Implications of localized energy deposition by Auger processes. Radiation Research 109: 78-89.
28. Kishikawa H, Wang K, Adelstein SJ, Kassis AI. 2006. Inhibitory and stimulatory bystander effects are differentially induced by Iodine- 125 and Iodine-123. Radiation Research 165: 688-694.
29. Lehnert S, Greene D, Batist G. 1990. Radiation response of drug-resistant variants of a human breast cancer cell line: The effect of glutathione depletion. Radiation Research 124: 208-215.
30. Lentz SI, Edwards JL, Backus C, McLean LL, Haines KM, Feldman EL. 2010. Mitochondrial DNA (mtDNA) biogenesis: Visualization and dual incorporation of BrdU and EdU into newly synthesized mtDNA in vitro. The Journal of Histochemistry and Cytochemistry 58: 207-218.
31. Magnusson J, Orth M, Lestienne P, Taanman JW. 2003. Replication of mitochondrial DNA occurs throughout the mitochondria of cultured human cells. Experimental Cell Research 289: 133-142.
32. Mothersill C, Seymour C. 1997. Medium from irradiated human epithelial cells but not human fibroblasts reduces the clonogenic survival of unirradiated cells. International Journal of Radiation Biology 71: 421-427.
33. Myers DK, Feinendegen LE. 1975. Double labeling with [3H]thymidine and [125I]iododeoxyuridine as a method for determining the fate of injected DNA and cells in vivo. The Journal of Cell Biology 67: 484-488.
34. Nagasawa H, Little JB. 1992. Induction of sister chromatid exchanges by extremely low doses of alpha-particles. Cancer Research 52: 6394-6396.
35. Neti PV, Howell RW. 2003. When may a nonuniform distribution of 131I be considered uniform? An experimental basis for multicellular dosimetry. Journal of Nuclear Medicine 44: 2019-2026.
36. Neti PV, Howell RW. 2004. Isolating effects of microscopic nonuniform distributions of 131I on labeled and unlabeled cells. Journal of Nuclear Medicine 45: 1050-1058.
37. Neti PV, Howell RW. 2006. Log normal distribution of cellular uptake of radioactivity: Implications for biologic responses to radiopharmaceuticals. Journal of Nuclear Medicine 47: 1049-1058.
38. Persaud R, Zhou H, Baker SE, Hei TK, Hall EJ. 2005. Assessment of low linear energy transfer radiation-induced bystander mutagenesis in a three-dimensional culture model. Cancer Research 65: 9876-9882.
39. Persaud R, Zhou H, Hei TK, Hall EJ. 2007. Demonstration of a radiation- induced bystander effect for low dose low LET beta-particles. Radiation and Environmental Biophysics 46: 395-400.
40. Petrovski G, Zahuczky G, Katona K, Vereb G, Martinet W, Nemes Z, Bursch W, Fesus L. 2007. Clearance of dying autophagic cells of different origin by professional and non-professional phagocytes. Cell death and differentiation 14: 1117-1128.
41. Pinto M, Azzam EI, Howell RW. 2006. Bystander responses in three-dimensional cultures containing radiolabeled and unlabeled human cells. Radiation Protection Dosimetry 122: 252-255.
42. Pinto M, Howell RW. 2007. Concomitant quantification of targeted drug delivery and biological response in individual cells. BioTechniques 43: 64, 66-71.
43. Pinto M, Azzam EI, Howell RW. 2010. Investigation of adaptive responses in bystander cells in 3D cultures containing tritium-labeled and unlabeled normal human fibroblasts. Radiation Research 174: 216-227.
44. Urashima T, Nagasawa H, Wang K, Adelstein SJ, Little JB, Kassis AI. 2006. Induction of apoptosis in human tumor cells after exposure to Auger electrons: Comparison with gamma-ray exposure. Nuclear Medicine and Biology 33: 1055-1063.
45. Weigel MT, Dahmke L, Schem C, Bauerschlag DO, Weber K, NiehoffP, Bauer M, Strauss A, Jonat W, Maass N and others. 2010. In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells. BMC Cancer 10: 412.
46. Wright EG. 1998. Radiation-induced genomic instability in haemopoietic cells. International Journal of Radiation Biology 74: 681-687.
47. Wright EG, Coates PJ. 2006. Untargeted effects of ionizing radiation: Implications for radiation pathology. Mutation Research 597: 119-132.
48. Wu H, Dhawan A, Howell RW. 2010. MIRDcell [Java]. Version 1.0. Newark, NJ, UMDNJ New Jersey Medical School. http://njmsweb04. umdnj.edu/
49. Xue LY, Butler NJ, Makrigiorgos GM, Adelstein SJ, Kassis AI. 2002. Bystander effect produced by radiolabeled tumor cells in vivo. Proceedings of the National Academy of Sciences of the USA 99: 13765-13770.
50. Yasui LS, Hofer KG. 1986. Role of mitochondrial DNA in cell death induced by I-125 decay. International Journal of Radiation Biology 49: 601-610.
51. Zhou HN, Randers-Pehrson G, Hei TK. 2000. Studies of bystander mutagenic response using a charged particle microbeam. Radiation Research 153: 234-235.